Fixed-dose Combination of Obicetrapib and Ezetimibe for LDL Cholesterol Reduction (TANDEM): a Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial.

Ashish Sarraju, Danielle Brennan, Kierstyn Hayden, Amanda Stronczek, Anne C Goldberg, Erin D Michos, Darren K McGuire,Denise Mason, Grace Tercek, Stephen J Nicholls,Douglas Kling, Annie L Neild,John Kastelein,Michael Davidson, Marc Ditmarsch, Steven E Nissen

Lancet (London, England)（2025）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined